Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Cash (2016 - 2022)

Historic Change in Cash for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to $4.8 million.

  • RedHill Biopharma's Change in Cash fell 2303.98% to $4.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$9.4 million, marking a year-over-year decrease of 351666.67%. This contributed to the annual value of -$961000.0 for FY2024, which is 9331.57% up from last year.
  • RedHill Biopharma's Change in Cash amounted to $4.8 million in Q4 2022, which was down 2303.98% from -$11.8 million recorded in Q3 2022.
  • In the past 5 years, RedHill Biopharma's Change in Cash ranged from a high of $52.5 million in Q1 2020 and a low of -$59.4 million during Q2 2020
  • For the 5-year period, RedHill Biopharma's Change in Cash averaged around $178300.0, with its median value being $1.0 million (2019).
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 97331.45% in 2020, then plummeted by 82101.54% in 2021.
  • RedHill Biopharma's Change in Cash (Quarter) stood at $10.3 million in 2018, then soared by 67.7% to $17.3 million in 2019, then plummeted by 82.19% to $3.1 million in 2020, then surged by 101.13% to $6.2 million in 2021, then decreased by 23.04% to $4.8 million in 2022.
  • Its last three reported values are $4.8 million in Q4 2022, -$11.8 million for Q3 2022, and -$1.8 million during Q2 2022.